US Markets in:   hrs   min   sec

Set StockTrendNews.com as your Homepage! - Click Here Home     About Us     Subscribe     Contact
 
StockTrendNews (STN) Exclusive: Cytokinetics Inc
Enter Symbol or Keywords
x
Cytokinetics, Incorporated's OPS Ranking Upgraded by StockDiagnostics.com   Stock Quote: (NGM:CYTK)
11/20/2009  
3.30 -0.02 -0.60% 341,513
Cytokinetics, Incorporated's OPS Ranking Upgraded by StockDiagnostics.com  
Last Price Change % Chg Volume
Sarasota, FL, November 20, 2009-Cytokinetics, Incorporated (NASDAQ:CYTK) reported positive OPS (Operational-cashflow Per Share) for its quarter ended September 30, 2009 and StockDiagnostics.com has up ... read full story  
Website Address: www.cytokinetics.com
Industry: Biomaterial & Tissue Engineering
Most Recent STN Exclusives
x
03/19/2010
T12-NEWS reports that the MedClean's Revenue for its 3 months ended December 31, 2009 Increased by 52.47%
03/19/2010
Ten Year High in EBITDA for BlackRock
03/19/2010
EBITDA Increases 109% for Agilent
03/19/2010
Western Refining's EBITDA Turns Negative for its Twelve Months
03/19/2010
Two Year High in Cash Flow from Operations for Smithfield Foods
03/19/2010
Vina Concha y Toro's Free Cash Flow Turns Positive for its Twelve Months
03/19/2010
OPS Ranking of "2" Reiteration for STMicroelectronics
03/19/2010
EBITDA for Smucker Reaches Fourteen Year High
03/19/2010
EBITDA for Liberty Acquisition Deteriorates more than 1,000%
03/19/2010
StockDiagnostics.com Reiterates Quiksilver's OPS Ranking of "1"
Interactive Chart: CYTK
x
More STN Exclusives for: CYTK
x
11/24/2009
Cytokinetics, Incorporated's EBITDA Turns Positive for its Twelve Months
11/20/2009
Cytokinetics, Incorporated's Revenue Up 575.97% over latest 12 months according to T12-NEWS
11/20/2009
Cytokinetics, Incorporated's OPS Ranking Upgraded by StockDiagnostics.com
... more CYTK exclusives
Other News Sources: CYTK
x
03/19/2010
Cytokinetics Announces Opening of a Phase IIa Evidence of Effect" Clinical Trial of CK-2017357 for Patients With Amyotrophic Lateral Sclerosis"
03/16/2010
Cytokinetics Announces Changes to Its Board of Directors
03/10/2010
Cytokinetics Announces Orphan Drug Designation Granted to CK-2017357 for the Treatment of Amyotrophic Lateral Sclerosis
... more CYTK news from other sources
Daily Market Updates
x
03/19/2010
Stocks Break Eight-Day Winning Streak and End With Losses
Despite a quadruple witching day" today ... read full story

30 Day Free Trial - MarketWatch Retirement Weekly

Free 30 Day Trial -MarketWatch Hulbert Interactive

Visit Tradesight



Sponsored Links
Attend a Free Webinar on How to Trade Stocks
InvestView.com
Increase Your Stock Market Performance by Using the News Management Interface that the Pros Use
Knobias.com

 
 
 
x


 
x
     
 
©2010 StockTrendNews.com
Disclaimer Terms of Sales Privacy About Us